West Pharmaceutical Services Other Long-Term Assets 2010-2024 | WST

West Pharmaceutical Services other long-term assets for the quarter ending June 30, 2024 were $0.050B, a 24.32% increase year-over-year.

  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
  • West Pharmaceutical Services other long-term assets for 2021 were $0.039B, a 67.52% increase from 2020.

West Pharmaceutical Services Other Long-Term Assets 2010-2024 | WST

  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
  • West Pharmaceutical Services other long-term assets for 2021 were $0.039B, a 67.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.9B
McKesson (MCK)$66.3B
Cardinal Health (CAH)$27B
Cooper (COO)$22B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9.2B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.5B
Lifevantage (LFVN)$127M
Pro-Dex (PDEX)$86M